VAERS 2414381
GLAXOSMITHKLINE BIOLOGICALS · TDAP (BOOSTRIX) · Charge ED2EN
- Staat
- OK
- Alter
- -
- Geschlecht
- U
- Eingang
- 18.08.2022
- Impfdatum
- 29.01.2018
- Beginn
- 29.01.2018
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Symptomtext
the vaccine may be already expired at the moment of vaccination; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a patient who received DTPa (Reduced antigen) (Boostrix) (batch number ED2EN, expiry date unknown) for prophylaxis. Co-suspect products included dtpa vaccine. pre-filled syringe device (Boostrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 29th January 2018, the patient received Boostrix and Boostrix Pre-Filled Syringe Device. On 29th January 2018, unknown after receiving Boostrix and Boostrix Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 10-Aug-2022 Reporter's comments: A medical assistant provided a lot number of Boostrix vaccine because a patient was administered with the vaccine and the vaccine might be already expired at the moment of vaccination. The consent to follow up was granted. Additional Supportive Information: As patient received expired vaccine, which led to expired vaccine used.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -